APPLICATION
ANDA218740
TYPE
ANDA
ORIGINAL APPROVAL
2026-04-29
LATEST ACTION
2026-04-29
ROUTE
SUBCUTANEOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
CETRORELIX ACETATEPrescription
CETRORELIX ACETATE EQ 0.25MG BASE/VIAL · POWDER · SUBCUTANEOUS
Approval history
2026-04-29UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.